5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.13▼ | 2.13▼ | 2.13▼ | 2.09▲ | 2.01▲ |
MA10 | 2.14▼ | 2.15▼ | 2.16▼ | 2.12▲ | 2.26▼ |
MA20 | 2.16▼ | 2.17▼ | 2.14▼ | 2.04▲ | 2.25▼ |
MA50 | 2.13▼ | 2.10▲ | 2.11▲ | 2.29▼ | 1.51▲ |
MA100 | 2.11▲ | 2.11▲ | 2.06▲ | 2.23▼ | 1.26▲ |
MA200 | 2.11▲ | 2.04▲ | 2.08▲ | 1.57▲ | 4.76▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.009▼ | -0.005▼ | 0.028▲ | -0.093▼ |
RSI | 43.376▼ | 47.838▼ | 50.906▲ | 50.464▲ | 54.199▲ |
STOCH | 25.139 | 5.347▼ | 15.144▼ | 57.348 | 14.468▼ |
WILL %R | -93.750▼ | -94.118▼ | -57.143 | -31.081 | -75.008▼ |
CCI | -59.792 | -64.139 | -55.511 | 52.816 | -61.769 |
Thursday, May 16, 2024 04:00 AM
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the online publication of a peer reviewed paper ...
|
Thursday, May 16, 2024 04:00 AM
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the online publication of a peer reviewed paper ...
|
Wednesday, May 15, 2024 02:29 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 2.155 | 2.155 | 2.125 | 2.13 | 182,687 |
15/05/24 | 2.08 | 2.2199 | 2.08 | 2.21 | 312,749 |
14/05/24 | 2.03 | 2.14 | 2.02 | 2.09 | 205,128 |
13/05/24 | 2.06 | 2.075 | 2.00 | 2.025 | 153,809 |
10/05/24 | 2.09 | 2.11 | 1.91 | 2.01 | 271,809 |
09/05/24 | 2.10 | 2.12 | 2.065 | 2.09 | 106,601 |
08/05/24 | 2.20 | 2.2191 | 2.0885 | 2.13 | 188,656 |
07/05/24 | 2.14 | 2.245 | 2.13 | 2.21 | 301,497 |
06/05/24 | 2.17 | 2.17 | 2.09 | 2.15 | 178,293 |
03/05/24 | 2.22 | 2.22 | 2.065 | 2.11 | 231,334 |
|
|
||||
|
|
||||
|
|